Debora Dumont
Co-Founder & Managing Partner @ Bioqube Ventures
Debora Dumont is a seed investor at Bioqube Ventures focused on Biotechnology and Therapeutics. Debora Dumont is the Managing Partner & Co-founder at Bioqube Ventures. He attended Hasselt University in 2002.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Debora Dumont invests in
Stages Debora Dumont invests in
Countries Debora Dumont invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 3 (75%)
- Therapeutics 2 (50%)
- Life Science 1 (25%)
Stage
- Seed 2 (50%)
- Series A 1 (25%)
Country
- Belgium 1 (25%)
- United States 1 (25%)
- The Netherlands 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Spica Therapeutics is a biotech company to transform macrophage biology into breakthrough therapies for patients. | $11.4M / Seed / Jun 04, 2025 | ||
| Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavois developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications | $9.4M / Seed / May 02, 2023 | ||
Enhanc3D Genomics
|
Enhanc3D Genomics is a spinout company from Babraham Institute. | $11.2M / Series A / Oct 20, 2022 | |
| Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavois developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications | $24M / Seed / Apr 22, 2021 |
Co-Investors
About Bioqube Ventures
Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.
Bioqube Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Debbie Dumont
Co-founder and Managing Partner
|
|||
|
Debora Dumont
Co-Founder & Managing Partner
|
|||
Dirk Reyn
Managing Partner
|
|||
Nico Vandervelpen
Co-founder and Managing Partner
|
|||
Tom Heyman
Executive Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Debora Dumont invest in?
Debora Dumont invests primarily in Biotechnology, Therapeutics and Life Science startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Debora Dumont?
Public channels for Debora Dumont include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Debora Dumont last invest?
The most recent investment recorded for Debora Dumont closed in Jun 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
